ADAPT Biotargeting System™ is a proprietary, minimally invasive platform that uses a broad library of synthetically manufactured molecules that bind to biological targets and characterize complex biological systems in their native state(s).

A New Platform for Rx and Dx Development

  • Proprietary, highly multiplexed technology to characterize complex biological systems in their native state(s) and to identify novel diagnostic and therapeutic targets
  • Minimally invasive “liquid biopsy” to diagnose complex conditions, monitor disease progression and assess therapeutic response
  • Platform for exploration of polyligands as a direct therapeutic moiety

 

ADAPT Biotargeting System Utility
Click Image Above To View Larger